Arvinas (ARVN) Free Cash Flow (2017 - 2026)

Arvinas' (ARVN) quarterly Free Cash Flow came in at -$70.5 million in Q1 2026, up 21.05% year-on-year from -$58.2 million in Q1 2025, and down 143.1% quarter-over-quarter from -$29.0 million in Q4 2025.

Arvinas (ARVN) Free Cash Flow (2017 - 2026) Analysis & Trends

Arvinas' Free Cash Flow history runs 10 years deep, the most recent figure standing at -$70.5 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 21.05% year-over-year to -$70.5 million in Q1 2026; TTM through Mar 2026 was -$255.3 million, a 0.95% decrease from a year earlier, with the FY2025 full-year figure at -$274.1 million, down 4.98% from the prior year.
  • Free Cash Flow eased to -$70.5 million in Q1 2026 per ARVN's latest filing, from -$29.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $49.5 million in Q2 2024 and bottomed at -$128.7 million in Q3 2024.
  • The 5-year median for Free Cash Flow is -$83.2 million (2023), against an average of -$72.4 million.
  • Across the five-year window, Free Cash Flow surged 155.43% in 2024 and sank 295.15% in 2025, its largest moves.
  • Year by year, Free Cash Flow stood at -$71.0 million in 2022, then dropped by 17.18% to -$83.2 million in 2023, then decreased by 1.44% to -$84.4 million in 2024, then soared by 65.64% to -$29.0 million in 2025, then plunged by 143.1% to -$70.5 million in 2026.
  • Per Business Quant, the three latest ARVN Free Cash Flow figures stand at -$70.5 million (Q1 2026), -$29.0 million (Q4 2025), and -$59.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Arvinas 519.68 Mn -95.22 Mn - -70.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -70.50 Mn
Mar 31, 2026 -70.50 Mn
Dec 31, 2025 -29.00 Mn
Dec 31, 2025 -29.00 Mn
Sep 30, 2025 -59.20 Mn
Sep 30, 2025 -59.20 Mn
Jun 30, 2025 -96.60 Mn
Jun 30, 2025 -96.60 Mn
Mar 31, 2025 -89.30 Mn
Mar 31, 2025 -89.30 Mn
Dec 31, 2024 -84.40 Mn
Dec 31, 2024 -84.40 Mn
Sep 30, 2024 -128.70 Mn
Sep 30, 2024 -128.70 Mn
Jun 30, 2024 49.50 Mn
Jun 30, 2024 49.50 Mn
Mar 31, 2024 -97.50 Mn
Mar 31, 2024 -97.50 Mn
Dec 31, 2023 -83.20 Mn
Dec 31, 2023 -83.20 Mn